Parkinson's disease (PD) is one of the most common age-related neurodegenerative diseases and affects millions of people worldwide. Strong evidence supports the role of free radicals, oxidative stress, mitochondrial, and proteasomal dysfunctions underlying neuronal death in PD. Environmental factors, especially pesticides, represent one of the primary classes of neurotoxic agents associated with PD, and several epidemiological studies have identified the exposure of the herbicide paraquat (PQ) as a potential risk factor for the onset of PD. The objective of our study was to investigate the neuroprotective effects of the standardized extracts of Bacopa monniera (BM) against PQ-induced and 1-methyl-4-phenyl-pyridinium iodide (MPP 1 )-induced toxicities and to elucidate the mechanisms underlying this protection. Our results show that a pretreatment with the BM extract from 50 mg/ml protected the dopaminergic SK-N-SH cell line against MPP 1 -and PQ-induced toxicities in various cell survival assays. We demonstrate that BM pretreatment prevented the depletion of glutathione (GSH) besides preserving the mitochondrial membrane potential and maintaining the mitochondrial complex I activity. BM pretreatment from 10.0 mg/ml also prevented the generation of intracellular reactive oxygen species and decreased the mitochondrial superoxide level. BM treatment activated the nuclear factor erythroid 2-related factor 2 pathway by modulating the expression of Keap1, thereby upregulating the endogenous GSH synthesis. The effect of BM on the phosphorylation of Akt further strengthens its role in the promotion of cell survival. By preserving the cellular redox homeostasis and mitochondrial activities and by promoting cell survival pathways, BM extract may have therapeutic uses in various age-related neurodegenerative diseases such as PD.
Parkinson's disease (PD) is the second most common agerelated neurodegenerative disease and affects millions of people worldwide. It is characterized by the selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) of the brain and deposition of alpha (a)-synuclein containing Lewy's bodies, leading to the characteristic motor and nonmotor symptoms (Braak et al., 2003; Lang and Lozano, 1998) . The specific mechanisms underlying neuronal death in PD are not clearly understood, but strong evidence supports the role of free radicals, oxidative stress, mitochondrial, and proteasomal dysfunctions (Przedborski, 2005) . For instance, there is a profound loss of the antioxidant glutathione (GSH) in the substantia nigra (SN) from PD patients (Jenner, 1993) . Recently, the ubiquitin-proteasome system (UPS), which is responsible for removing damaged and misfolded proteins, has been implicated in PD pathogenesis as a decrease in proteasome activity was reported in postmortem brains with sporadic PD (McNaught et al., 2003) . The first evidence of mitochondrial complex I involvement in the pathophysiology of PD came from drug users who were accidentally exposed to 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine (MPTP) and developed PD because the metabolite of MPTP, i.e., 1-methyl-4-phenyl-pyridinium iodide (MPP þ ) is an inhibitor of the complex I (Langston et al., 1983) . Only 5-10% of PD cases are genetically related, and the suggestion that environmental factors play a role in the etiology of PD have gained attention since the discovery of the neurotoxins MPTP and MPP þ . Among different environmental factors, pesticides especially that cause mitochondrial dysfunction and oxidative stress represent one of the primary classes of neurotoxic agents associated with PD (Moretto and Colosio, 2011; Tanner et al., 2011) . Paraquat (PQ), which includes diquat and cyperquat, is a bipyridyl compound widely used as herbicide with a structure similar to MPP þ . Several epidemiological studies have identified PQ exposure as a potential risk factor for the onset of PD (Hatcher et al., 2008; Tanner et al., 2011) . PQ was first produced in 1961 and gained considerable attention because of its extreme toxicity in human and its systemic exposure has been shown to be able to cross the blood-brain barrier through the neutral amino acid transporter and to selectively damage the nigrostriatal dopaminergic system in mice, causing a 20-30% selective dopamine neuronal loss in the SNpc (McCormack and Di Monte, 2003) . Although exact mechanisms by which PQ induces PD in animal models are still unknown, several studies have shown that it produces oxidative stress through redox cycling with a variety of cellular diaphorases and oxygen to produce superoxide radicals (Castello et al., 2007; Wu et al., 2005) . Superoxide produced through the redox cycling is further converted into H 2 O 2 by the superoxide dismutase, thereby further increasing the cellular oxidative stress.
Prevalence of PD in Asian Indians is at least three times lower as compared with British Caucasians (Muthane et al., 1998) , and unlike in the Americans there is no age-related loss of SNpc neurons in Asian Indians, which could be attributed to genetic, environmental, or dietary causes (Alladi et al., 2009) . Bacopa monnieri, Linn. (Brahmi, BM) has been used in Indian Ayurvedic traditional medicine for almost 3000 years. BM is classified as a drug used to improve memory and cognition and as a potent nerve tonic (Howes and Houghton, 2003; Russo and Borrelli, 2005) . BM has been found to be well tolerated without side effects (Russo and Borrelli, 2005) , and the LD 50 in rats was determined to be as high as 2.7 g/kg when administrated orally (Hota et al., 2009) . Although the BM extract and bacosides compounds have been investigated extensively for their neuropharmacological activities, their beneficial effect on cellular pathways involved in the physiopathology of PD remain to be established. We have thus initiated this study to test the hypothesis that BM pretreatment can protect human dopaminergic cells against oxidative stress and mitochondrial dysfunctions. Because a multiple hit hypothesis has been proposed in the progress and development of PD (Sulzer, 2007) , the botanical extracts containing multiple classes of chemical entities with synergic properties may hold better promise, therapeutic benefits, and applicability in neuroprotection as compared to a single chemical entity.
Our results show that BM-induced neuroprotection is mediated through the preservation of intracellular GSH level and mitochondrial functions, decreasing the intracellular reactive oxygen species (ROS) and scavenging mitochondrial superoxide anions besides modulating proteasomal activity. Furthermore, BM treatment also activated the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, the master regulator of genes encoding for antioxidants and detoxifying phase II enzymes, and the Akt, a cell survival pathway.
MATERIALS AND METHODS
Dulbecco's minimal essential medium (DMEM), fetal bovine serum (FBS), penicillin/streptomycin, L-glutamine, MPP þ , b-nicotinamide adenine dinucleotide reduced dipotassium salt (NADH), b-nicotinamide adenine dinucleotide phosphate reduced tetrasodium salt (NADPH), coenzyme Q10 (CoQ10), rhodamine 123, dihydroethidium (DHE), Tox-2 (XTT based), Tox-8 (resazurin based), phenazine methosulfate (PMS), 1-chloro-2,4-dinitrobenzene (CDNB), L-glutathione reduced (GSH), glutathione reductase (GR), tert-butyl hydroperoxide (TBH), and proteases inhibitor cocktail were obtained from Sigma-Aldrich Inc. L-glutathione oxidized (GSSG) and Suc-LLVY-7-amino-4-methylcoumarin (AMC), fluorogenic substrate for measuring the chymotrypsin-like peptidase activity of the 20S proteasome, were from Calbiochem and Boston Biochem, respectively. The cytotoxicity detection kit, based on lactate dehydrogenase (LDH) was from Roche Diagnostics. Monochlorobimane (MCB), 2#,7#-dichlorofluoroscein diacetate (DCF-DA), and MitoSox red were from Molecular Probes, whereas PQ and diquat mixture was from Ultrascientific. Iodonitrotetrazolium chloride (INT) was from Serva Electrophoresis GmbH (Heidelberg, Germany). BCA protein estimation kit was from Pierce Biotechnology (Rockford, IL).
Rabbit polyclonal anti-Akt, phospho-Akt (pAkT) (Cell Signaling), rabbit polyclonal anti-Nrf2, and gamma-glutamylcysteine synthetase (c-GCS) antibodies were from Abcam, mice monoclonal anti-b actin antibody (SigmaAldrich Inc.), mice monoclonal anti-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (Millipore), and monoclonal anti-rabbit to Creb (Cell Signaling) were used in Western blot analysis. Rabbit and mice horseradish peroxidase (HRP)-conjugated secondary antibodies were obtained from SigmaAldrich Inc. Fluorescence emission with different probes was recorded using the Synergy HT Multi-Detection Microplate Reader.
Standardized extracts of BM. Standardized extracts of BM were kindly provided by Natural Remedies Private Limited, Bangalore, India. BM and BM2 were certified to contain 11.5 and 40% of total bacosides, respectively, as determined by high performance thin layer chromatography. Details composition of the BM2 extract has been described by us earlier (Singh et al., 2010) . BM extract further contained these bioactive phytocompounds, i.e., bacoside A3 (1.5%), bacopaside II (1.3%), jujubogenin isomer of bacopasaponin C (1.6%), bacopasaponin C (1.0%), bacopaside I (1.1%), bacosine (0.2%), apigenin (0.1%), and luteolin (0.2%) as determined by high performance liquid chromatography.
Cell culture and treatment. SK-N-SH cells, a human neuroblastoma cell line from American Type Cell Culture (ATCC, Rockville, MD), were maintained in DMEM supplemented with 10% (vol/vol) FBS, 100 U/ml penicillin, and 100 lg/ml streptomycin. SK-N-SH cells were plated at a density of 2.0 3 10 4 cells/well in 96 well plates (Corning, NY) and incubated at 37°C. After 24 h of plating, the media was completely removed, and cells were kept in DMEM with antibiotics but without serum. Cells were treated with different doses of BM extracts for 3 h prior to treatment with different toxicants, i.e., MPP þ (2.5mM) and PQ (100lM) for 24 h. These doses were selected following a dose-effect study (data not shown) and correspond to the LD 50 after 24 h of treatment. Bacosides have been shown to be stable in phosphate buffer solution between pH 6.8 and 9.0 at least for 5 days (Phrompittayarat et al., 2008) .
Cytotoxicity and cell viability assays. Cytotoxicity and cell survival were measured by using LDH, XTT, and resazurin assays by using commercial kits as described previously (Singh et al., 2010) . XTT assay reflects metabolic alterations, and XTT-based test alone would lead to the underestimation of the number of living cells. Therefore, a valuable approach would be to integrate this assay with another one, allowing for the cross confirmation of the cytotoxicity and proliferation data sets. XTT assay was thus completed with the resazurin test. To distinguish between toxicity and proliferation effects of the BM extracts, LDH assay, which measures the cellular membrane integrity and is a mean of quantifying dead cells was also done. The control value was considered as 100%, and cell survival was expressed as a percentage of the control value.
Intracellular reduced GSH level and mitochondrial membrane potential (MMP-nw m ). Intracellular GSH level and mitochondrial membrane potential (MMP) levels were measured by using the cell permeable fluorescent dyes MCB and rhodamine 123, respectively, as previously described (Singh et al., 2010) . After 24 h of plating, the media was completely removed and SK-N-SH 220 SINGH, MURTHY, AND RAMASSAMY cells were kept in DMEM containing antibiotics but without serum. Then cells were pretreated with BM for 3 h followed with MPP þ (2.5mM) for 6 h. After treatment, the media was removed, and cells kept either in an MCB solution (100lM) or in a rhodamine 123 solution (5.0lM) for 30 min, and fluorescence was read as previously described (Singh et al., 2010) .
Total mitochondrial NADH dehydrogenase activity. Total mitochondrial NADH dehydrogenase activity in intact cells was measured as previously described (Singh et al., 2010) . After 24 h of plating, the media was completely removed, and SK-N-SH cells were kept in DMEM without phenol red and serum. Cells were treated with different doses of BM for 3 h followed with 2.5mM of MPP þ along with 50lM each of INT and PMS. INT is a NADH dehydrogenase substrate and PMS is an intermediate electron carrier used to enhance the sensitivity of the reaction. After 6 h of incubation at 37°C, the absorbance of culture media was measured at 490 nm using a multiwell microplate reader. The activity is expressed as total NADH dehydrogenase activity, and activity of nontreated control cells is assumed to be 100%.
Mitochondrial complex I activity. Mitochondrial complex I activity was measured in enriched mitochondria fractions isolated from SK-N-SH cells according to the method of Birch-Machin and Turnbull (2001) with slight modifications. Briefly SK-N-SH cells were plated in 75 cm 2 flasks in DMEM containing serum and antibiotics. After 72 h, the media was completely removed, and the flasks were rinsed with PBS. Cells were then harvested and collected in isolation buffer containing 225mM mannitol, 75mM sucrose, 10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, and 200lM EDTA at pH 7.4. After a short centrifugation at 1300 3 g for 5 min at 4°C, the supernatants were decanted into new tubes and centrifuged at 10,000 3 g for 10 min. The resulting supernatants were discarded, and the pellet was resuspended as mitochondrial enriched fraction in isolation buffer. The activity of complex I was measured spectrophotometrically at k340 nm in a buffer containing 25mM KH 2 PO 4 (pH 7.2), 5.0mM MgCl 2 , 3mM potassium cyanide, and 2.5 mg/ml bovine serum albumin in the presence of 125lM of NADH and CoQ10. Briefly the mitochondria fraction (80 lg), BM, and MPP þ were incubated in the assay buffer (100 ll) for 15 min. To initiate the reaction, 100 ll of NADH and CoQ10 solutions were added, and the plate was read for 5 min in a microplate reader, and OD was recorded after a 1-min interval.
Measurement of proteasome activity. Proteasomal activity was monitored by using fluorogenic substrate, which measures the chymotrypsin-like activity of the 20S proteosome. SK-N-SH cells were kept in DMEM without serum and pretreated for 3 h with BM (60 lg/ml) followed with 2.5mM of MPP þ for 24 h.
At the end of the treatments, total proteins were isolated in complete lysis buffer as previously described (Singh et al., 2010) . Equal amount of protein (50 lg/well) was incubated in an assay buffer (20mM Tris-Cl, pH 7.5, 1mM EDTA, 1mM NaN 3 , 1mM DTT, 0.03% SDS) along with 50lM of Suc-LLVY-AMC for 30 min at 37°C. The fluorescence of the resulting free cleaved substrate peptide AMC was recorded with kex at 360 nm and kem at 460 nm.
Intracellular ROS. Intracellular ROS generation was monitored by following the oxidation of DCF-DA, a cell permeable dye which, upon hydrolysis by intracellular esterases, reacts with H 2 O 2 to produce a highly fluorescent compound, DCF, which is trapped inside the cells. Briefly, after 40 min of treatment with 200lM of either H 2 O 2 or PQ, DCF-DA was added to a final concentration of 10lM for 20 min. Cells were then washed with PBS, and the fluorescence was recorded as previously described (Singh et al., 2010) .
Superoxide anion generation. Superoxide anion production from PQ treatment in SK-N-SH cells was determined by using fluorescent dyes MitoSox red and DHE, which measure the level in mitochondrial and cytosolic compartments, respectively. This assay is based on the reduction of ethidium by superoxide anion to a fluorescent compound ethidium (Bindokas et al., 1996) . After 24 h of plating, the media was completely removed, and SK-N-SH cells were kept in DMEM containing antibiotics but without serum. Then cells were pretreated with BM for 1 h followed with PQ (200lM) for 1 h. After treatment, the media was removed, and cells were kept either in a MitoSox red solution (1.0lM) or in a DHE solution (5.0lM) for 30 min. Then, the cells were washed with PBS, and cellular fluorescence was recorded with kex at 510 nm and kem at 580 nm.
Measurement of GR, glutathione peroxidase, and glutathione S-transferase activities. SK-N-SH cells were kept in DMEM without serum and treated with different doses of BM for 24 h. After the treatments, total proteins were isolated in complete lysis buffer (pH 8.0) containing 50mM Tris-HCl, 150mM of NaCl, 0.1mM of EDTA, and DTT (1.0mM). After centrifugation (15,000 3 g, 10 min, 4°C), the supernatant was collected and assayed for the GR, glutathione peroxidase (GPx), and glutathione S-transferase (GST) activities.
GR activity was measured by using a slight modification of the previously described method (Bishop et al., 2007) . The reaction mixture (150 ll) contained 50 lg of protein, 1mM GSSG, and 0.2mM NADPH in 50mM of potassium phosphate buffer solution (pH 7.5) containing 1.0mM of EDTA. The activity of GR was determined by measuring the decrease of absorbance at 340 nm due to the oxidation of NADPH. The control values were taken as 100%, and data presented GR activity % of control.
Cellular GPx activity was measured by continuously monitoring the formation of oxidized glutathione (GSSG) from GPx-catalyzed oxidation of GSH by TBH, coupled with NADPH consumption in the presence of exogenously added GR providing for a constant level of GSH as described by Flohé and Günzler (1984) . The reaction mixture (200 ll) contained 50 lg of protein, 1mM GSH, 0.250mM NADPH, and GR (2.4 U/ml) in 50mM potassium phosphate (pH 7.0) containing 1.0mM EDTA. The plate was incubated at 37°C for 3 min. The reaction was started by addition of 50 ll of TBH (5mM), and the rate of NADPH utilization was monitored at 340 nm, 37°C for 5 min. The control values were taken as 100%, and data presented GPx activity % of control.
GST activity was measured by the method described by Habig et al. (1974) using CDNB as a substrate. Briefly, the reaction mix containing 1mM GSH and 1mM CDNB in 0.1M sodium phosphate buffer (pH 6.5) was prepared, and the reaction was started by adding 50 lg of protein (200 lg/ml), and the rate of formation of CDNB-GSH conjugate was monitored by measuring the increase of absorbance at 340 nm for 5 min. Alternatively, GST activity was also measured by using MCB as a substrate. Briefly, the reaction mix containing 0.5mM GSH and 0.5mM MCB in 0.1M sodium phosphate buffer (pH 6.5), and 25 lg of protein (100 lg/ml) was incubated at room temperature for 5 min, and the rate of formation of MCB-GSH conjugate was monitored by measuring fluorescence with kex at 360 nm and kem at 460 nm for 30 min. The control values were taken as 100%, and data presented GST activity % of control.
Expression of some of redox-regulated proteins. The activity of the redox-sensitive transcription factor Nrf2 was monitored in cytoplasmic and nuclear fractions, whereas that of Keap1, c-GCS, Akt, and pAkt was monitored in total proteins. SK-N-SH cells were plated at a density of 4.0 3 10 6 cells in 75 cm 2 flasks in DMEM containing serum and antibiotics. After 48 h, the media was completely removed, and cells were kept in DMEM containing antibiotics but without serum. For Nrf2 activation, cells were treated with a dose of BM (10, 20, and 60 lg/ml) for 1 and 24 h. After the treatment, cytoplasmic and nuclear proteins were obtained by using a nuclear protein extraction kit containing protease inhibitors. For Keap1, cells were treated with a dose of BM (10, 20, and 60 lg/ml) for 1 h. For Akt and pAkt, cells were treated with BM (10, 20, 30, and 40 lg/ml) for 1 h. After the treatments, total proteins were isolated in complete lysis buffer containing a cocktail of proteases and phosphate inhibitors as previously described (Singh et al., 2010) . The protein quantity in samples was estimated by using a BCA protein estimation kit. Proteins (25-30 lg) were separated on a 10% SDS-PAGE and transferred to polyvinylidene fluoride membranes. The membrane was blocked with 5% nonfat milk in TBS and then incubated overnight at 4°C with primary antibodies for c-GCS (1:500), Nrf2 (1:300), Akt (1:600), pAkt (1:500), and Keap1 (1:1000). Then, the membranes were washed three times with TBST and incubated with HRP-conjugated secondary antibodies. After final washings, the membranes were incubated with enhanced chemiluminescent Western blotting substrates (Millipore) for 5 min, and bands were STANDARDIZED EXTRACTS OF BACOPA MONNIERA 221 quantified by imaging densitometry using Flour Chem HD2 system from Alpha Innotech. GAPDH or Creb was used as internal protein control.
Statistical analysis. All results were confirmed with at least three separate experiments and expressed as mean ± SEM. Data were analyzed for statistical analysis by one-way ANOVA followed by a Dunnett's multiple means comparison test, and the level of significance was considered when p values < 0.05.
RESULTS

BM Extract Protects
The toxicity of MPP þ requires a dopaminergic neuronal phenotype (Schildknecht et al., 2009) . SK-N-SH cells are positive for tyrosine hydroxylase and also express dopamine transporters (Jiang et al., 2004) , therefore represent a suitable model to study the protective effect against MPP þ and PQ. Results in Figure 1 show that treatments with the BM extract for 3 h before the addition of 2.5mM of MPP þ protected SK-N-SH cells against MPP þ -induced toxicity. This protection was assessed 24 h after the addition of MPP þ through the survival XTT test, was completed with resazurin assay and was significant from 75 lg/ml (Figs. 1A and 1B) . However, higher metabolic activities observed with XTT and resazurin could be due to a proliferative effect of BM. In parallel, LDH release in the medium was measured 24 h after MPP þ treatment, and a significant protection was observed from 50 lg/ml of BM and reached a maximum at 100 lg/ml (Fig. 1C) . BM alone did not cause any cytotoxicity until the highest tested concentration (100 lg/ml) (data not shown). These colorimetric assays were correlated by microscopic examination of cell morphology. As shown in Figure 1D 
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Mitochondrial dysfunctions play a critical role in the pathogenesis of PD. In addition to complex I activity, succinate dehydrogenase is also decreased in SN of PD patients (Simunovic et al., 2009) . Next, we have investigated whether BM pretreatment could prevent the inhibition of the mitochondrial dehydrogenases and complex I induced by MPP þ . For this, SK-N-SH cells were pretreated with BM for 3 h followed by the addition of MPP þ (2.5mM) along with INT and PMS. Total NADH dehydrogenase activity was measured 3 h after MPP þ treatment. The total NADH dehydrogenase activity was decreased by 30% in the presence of MPP þ , but it was completely restored with BM pretreatment from 25 lg/ml (Fig. 2B) .
Mitochondrial complex I activity also was measured in mitochondrial-enriched fractions from SK-N-SH cells. Mitochondrial proteins were incubated with BM and MPP þ for 15 min and then complex I activity was monitored by the oxidation of NADH in the presence of CoQ10. Results in Figure 2C show that the BM treatment, from 50 lg/ml, significantly restored the complex I activity in mitochondria from SK-N-SH cells.
The association between mitochondrial dysfunction and the proteasomal system in PD has recently been a focus of interest (Domingues et al., 2008 ). An increase in the proteasome activity has been reported after treatment with MPP þ (Endo et al., 2009) . Our results show that the proteasomal enzymatic activities were increased in SK-N-SH cells after 24 h of treatment with MPP þ . Interestingly, a 3-h pretreatment with BM at 60 lg/ml significantly prevented the MPP þ -induced increase in the proteasomal activity (Fig. 2D ).
BM Treatment Preserves Intracellular GSH Level
A gradual decline of cellular GSH levels have been described in the presence of MPP þ indicating its potential to disturb the cellular redox potential and antioxidant defense systems (Schildknecht et al., 2009) . Our results in Figure 3 show that 3 h pretreatment with BM prevented the decrease of GSH levels induced after 6 h of treatment with 2.5mM of MPP þ .
Neuroprotective Effect of the Standardized Extracts of BM Against MPP þ Are Mediated Through the Bacosides
The BM extract contains triterpenoid saponins and flavonoids compounds. Bacosides, the triterpenoid saponins, have been reported to be active constituents responsible for the In order to analyze the involvement of bacosides in the neuroprotective effect observed with the BM extract, we have compared the efficacy of another standardized extract, i.e., BM2, which contains 40% of bacosides, whereas BM contains 11.5%. Interestingly, BM2 was more effective against MPP þ -induced toxicity, as the protection was significant from 1.0 lg/ml of BM2 and reached a maximum at 5.0 lg/ml (Figs. 4A and 4B) . These results strongly suggest that the neuroprotective effect of the BM extract is mediated through bacosides compounds.
BM Pretreatment Protects SK-N-SH Cells against PQInduced Toxicity and Decreases Intracellular ROS and Superoxide Anion Generation
PQ, a herbicide with a structural similarity to MPP þ , has also been used in in vitro models of PD. To further confirm the cytoprotective effect of BM, we completed XTT assay with PQ. As shown in Figure 5A , a significant protection was observed with 60 lg/ml of BM. To further investigate the involvement of the antioxidant effect of the BM extract in the neuroprotective effect against PQ, we next measured the intracellular levels of ROS using a cell permeable fluorescent probe DCF-DA. As expected, SK-N-SH cells treated with a high concentrations of PQ (200lM) for 1 h displayed intense fluorescence after staining with DCF dye, and this fluorescence was significantly decreased when cells were pretreated with BM from 10.0 lg/ml (Fig. 5B) .
PQ produces superoxide anions and mitochondria being one of the primary sources of PQ-induced ROS generation in the brain (Castello et al., 2007; Wu et al., 2005) . So, next we have measured the cytosolic and mitochondrial superoxide levels by using, respectively, the fluorescent dyes DHE and MitoSox red. As shown in Figures 5C and 5D , there was a significant increase in superoxide generation, which was more pronounced in mitochondrial compartment after PQ treatment. The production of superoxide anions was significantly prevented by BM pretreatment from 10.0 lg/ml.
Effects of BM on the GSH Synthesis Pathway and Phase II Antioxidant Enzymes
GSH pathway plays an important role in the protective effect against MPP þ and PQ. As indicated in Figure 3 , BM could prevent the decrease of GSH induced by MPP þ . To investigate whether BM could regulate the GSH pathway, we have next analyzed the effect of BM on the level of c-GCS, a rate-limiting enzyme involved in GSH synthesis (Griffith, 1999) . As shown in Figure 6A , a significant increase in c-GCS level was observed after 24 h of treatment with a dose of 60 lg/ml of BM. Interestingly, from 10.0 lg/ml, BM is also able to activate phase II antioxidant enzymes, i.e., GST, GR, and GPx (Figs. 6B and 6C) . These results are of great interest as the upregulation of the activities of GST, GR, and GPx can promote cell survival in response to oxidative stress (Kensler et al., 2007) , particularly in the presence of MPP þ or PQ. To gain insight into the mechanisms underlying the BM-induced GSH synthesis and phase II antioxidant enzymes such as GST, we have analyzed the effect of BM on the expression of Nrf2, a master regulator of cellular antioxidant response (Kensler et al., 2007) . After 1 h of treatment with different doses of BM (10, 20, and 60 lg/ml), a significant increase of Nrf2 was observed in the nuclear fraction (Fig. 7A) . On the other hand after 24 h of treatment, the activation of Nrf2 required higher dose of BM as it was significant only from 20 lg/ml (Fig. 7B ). Nrf2 can be activated either by selective inhibition of the Keap1 or by the activation of the phosphatidylinositol 3-kinase (PI3K)/ Akt (Cuadrado et al., 2009) . In parallel, results in Figure 7C indicate that the level of Keap1 is significantly decreased 1 h after BM treatment. Next, we have examined whether BM induced the PI3K/Akt pathway. Results in Figure 8 show a significant increase in the level of pAkt 1 h after BM treatment at 40.0 lg/ml.
DISCUSSION
Our study reports the protective effects of the BM extract on two toxins, i.e., MPP þ and PQ relevant and known to induce the biochemical deficits described in PD. Both toxins are well known to mediate a wide variety of neurotoxic effects such as the production of ROS, the alteration in the mitochondrial activity, and the induction of proteasome dysfunction. Although, MPP þ and PQ are structurally similar and are known to induce dopaminergic neuronal loss and a Parkinsonian-like syndrome in experimental animal models, they do not exert their toxicity in a similar manner. PQ has two positive charges and thus differs from MPP þ in polarity, with its toxicity being independent of the dopamine transporter (Richardson et al., 2005) . PQ exerts its toxicity by cellular redox cycling (Bonneh-Barkay et al., 2005) , a process in which it accepts an electron from an appropriate donor and subsequently reduces O 2 to produce superoxide anion radical (O 2 À ) (Drechsel and Patel, 2009 ), and it is not an efficient inhibitor of mitochondrial complex I (IC20 of 7mM) (Richardson et al., 2005) . These results prompted us to analyze the protective effect of BM on PQ and MPP þ in order to validate the pharmacological application of BM in neurodegenerative disorders such as PD.
Using the dopaminergic neuroblastoma SK-N-SH cells, our results showed that BM pretreatment protected SK-N-SH cells against MPP þ and PQ in LDH, XTT, and resazurin assays, which are measures of the membrane and mitochondrial integrity. Our results showed that the pretreatment with BM restored the mitochondrial activity and the depletion of GSH induced by MPP þ , reduced ROS, and superoxide anion levels in the presence of PQ, induced the expression of c-GCS, a ratelimiting enzyme in GSH biosynthesis, the activities of GST, GSH-PX, GSH-Red, the transcription factor Nrf2, and the phosphorylation of Akt. The protective effect of BM may be attributed to the presence of bioactive compounds, which may be responsible for quenching of free radicals, or alternatively, it may be due to the upregulation of antioxidant systems. Therefore, we have targeted the effects of BM on ROS and superoxide anion levels, on the GSH pathways, on the regulation of antioxidant systems through the Nrf2 activity, and on the cell survival pathway pAkt.
Initially, in the presence of MPP þ , we have investigated the effect of BM on the mitochondrial integrity as mitochondria have been established as the primary target of MPP þ , and it has been shown to accumulate in the mitochondria within a few minutes (Przedborski et al., 2004; Ramsay and Singer, 1986) . The effect of BM was evidenced through the MMP assay, the NADH dehydrogenase, and complex I activity. The protective effect of BM on mitochondria could be due to bacosides A present on the BM extract, as these compounds have been shown to maintain the structural and functional integrity of the mitochondrial membrane in the brain (Anbarasi et al., 2005) . These results are relevant to the physiopathology   FIG. 6 . Effects of BM on the levels of c-GCS and on the activities of GST, GR, and GPx in SK-N-SH. Cells were treated with BM at the indicated concentrations for 24 h. Levels of c-GCS proteins were measured by Western blot, and GAPDH was used as the loading control. Bar graphs represent quantitative results of ratio between total c-GCS and GAPDH. (B) GST activities were measured by CDNB and MCB and (C) GR and GPx activities were measured by monitoring the NADPH consumption. Data are means ± SEM of at least three separate experiments performed in quadruplicate in each group with *p < 0.05 and **p < 0.01 versus control groups. 226 SINGH, MURTHY, AND RAMASSAMY of PD as growing evidence implicates the impairment of the mitochondrial function such as the decrease in complex I (30%) and NADH dehydrogenase activities in the SN from PD (Schapira et al., 1989; Simunovic et al., 2009) .
In addition to the effect of BM on the mitochondrial activities, our data showed that BM could also prevent the increase of the proteasomal activity induced by MPP þ suggesting a positive effect of BM on the mitochondrial import system as MPP þ -induced dysfunctions of the mitochondrial import system have been shown to increase proteasome activity (Endo et al., 2009) . The effects of BM on mitochondrial functions could also be the result of the ability of the BM extract to maintain GSH levels. Indeed, there is interplay between GSH levels, mitochondrial dysfunction, and the proteasomal system. GSH has been shown to regulate mitochondrial ROS generation and GSH depletion is associated with inhibition of mitochondrial complex I (Chinta and Andersen, 2006; Shen et al., 2005) . In the SNpc of PD, the depletion of GSH is one of the earliest biochemical changes with a substantial decrease in GSH levels occurring prior to selective loss of complex I activity and dopamine loss. Moreover, the degree of GSH depletion correlates with the disease severity (Jenner, 1998; Riederer et al., 1989) . The GSH depletion seen in PD may result from a decrease in synthesis and recycling. In dopaminergic neurons, PQ, MPP þ , and DA are known to deplete GSH Graham, 1978; Schildknecht et al., 2009) . For instance, in the presence of MPP þ , a rapid efflux of dopamine from synaptic vesicular is observed triggering an increase in the cytoplasmic DA and ROS levels where GSH will play a very important role in the detoxification process (Hastings, 2009; Lotharius and O'Malley, 2000) . The (McNaught et al., 2003) . GSH depletion may also affect the UPS at the levels of E1 ubiquitin ligase. In dopaminergic cells, dopamine could induce irreversible proteasome inhibition via DA-derived quinones, and this inhibition could be abrogated by GSH (Zhou and Lim, 2009) . Therefore, the restoration of GSH by BM may have an important role in preserving the mitochondrial functions and maintaining effective clearance of misfolded and damaged proteins.
An important way of counteracting MPP þ -and PQ-induced toxicities in the dopaminergic neurons may therefore be by enhancing the level of antioxidant defense enzymes and GSH turnover (Chinta and Andersen, 2006; Garrido et al., 2011; Huang and Chuang, 2010) . Our results show that BM can modulate the GSH pathway through GSH synthesis and turnover with the elevation of the expression of c-GCS; a rate-limiting enzyme involved in GSH synthesis (Griffith, 1999) from 60 lg/ml. These results are relevant for the protection of dopaminergic cells because it has been reported that the activity of c-GCS is reduced throughout the brain as a consequence of the aging process (Zhu et al., 2006) . Our results also demonstrate that BM can modulate the GSH turnover by increasing the activities of GST, GSH-PX, and GSH reductase. Recent studies have shown that GST-Pi plays an important role in the progression of PD and protected mice against MPTP-induced neurotoxicity (Shi et al., 2009; Smeyne et al., 2007) . On the other hand, GR-regulated intracellular GSH recycling is an effective tool for cell survival under OS (Harvey et al., 2009) . Glutathione peroxidase 1 (GPX1) overexpression protected dopaminergic cells and mice against 6-hydroxydopamine (6-OHDA) and PQ-induced toxicity (Cheng et al., 1998; Gardaneh et al., 2011; Ridet et al., 2006) . Moreover, brain mitochondrial H 2 O 2 removal is primarily dependent on the GSH-PX and GSH reductase system (Zoccarato et al., 2004) .
The transcription factor Nrf2 is crucial for the efficient detoxification of reactive metabolites and ROS and is effective in blocking neurotoxicity resulting from GSH depletion and mitochondrial dysfunctions caused by complex I inhibitors (Cuadrado et al. 2009; Lee et al., 2003) . Because BM increased intracellular GSH and protect mitochondrial activity, we have investigated the Nrf2/Keap1 response after BM treatment. Western blots of cytosolic and nuclear fractions showed that BM treatment caused an increase in the abundance of nuclear Nrf2. To confirm the effect of BM on Nrf2 activity, we have demonstrated that BM can increase the expression of c-GCS, one of the downstream effectors of Nrf2 (Copple et al., 2008) . Nrf2 serves as a critical determinant of a cell's capacity to survive or succumb to a toxic insult. Our results suggest that BM, indirectly through the Nrf2 pathway, regulates the expression of numerous cytoprotective genes. Terpenoid compounds present in the BM extract could be involved in the activation of Nrf2, as it has been shown that synthetic terpenoid compounds are potent inducers of the antioxidant response element (ARE)/Nrf2/Keap1 signaling pathway. Triterpenoid saponins are known to activate the Nrf2/ARE pathways by forming a Michael adduct with reactive cysteine residues on Keap1 protein (Dinkova-Kostova et al., 2005) .
We have also investigated the degree of activation of the PI3K/Akt pathway as a candidate signal for the cytoprotective effect of BM because MPP þ -induced toxicity is associated with the inactivation of the PI3K/Akt signaling (Salinas et al., 2001) . Moreover, in dopaminergic neurons of the SN, pAkt is normally expressed at high levels with a diminution in PD brain suggesting that defective Akt pathway is linked to loss of dopaminergic neurons in PD (Timmons et al., 2009) . Our results show that BM can activate the Akt pathway from 40 lg/ml. By activating pAkt, BM could promote cell survival and cell growth by inactivating downstream substrates of Akt such as Bad, procaspase-9, and forkhead transcription factors (Cantley, 2002) . Nrf2 and Akt are of particular interest considering the progressive decline in Akt and Nrf2 activity with age resulting in loss of cellular redox homeostasis (Ikeyama et al., 2002; Suh et al., 2004) , BM could be an excellent candidate to prevent age-related decline in cellular GSH levels and preventing dopaminergic cell death (Fig. 9) .
The major chemical constituents isolated and characterized from BM are triterpenoid saponins. Several pharmacological (Singh and Dhawan, 1982; Singh et al. 1988 ) and clinical studies Stough et al., 2001) have identified several triterpenoid saponins as active constituents of the BM extract (Chakravarty et al., 2001; Murthy et al., 2006) . We have previously demonstrated the role of bacosides in BM-induced neuroprotection against various toxins (Singh et al., 2010) . In order to identify the involvement of bacosides compounds in the protective effect against MPP þ , we have compared the efficacy of the BM2 extract containing 40% of bacosides. The BM2 extract displayed higher efficacy against MPP þ -induced toxicity in SK-N-SH cells. These results are in accordance with the property of bacoside to maintain the structural and functional integrity of the mitochondrial membrane (Anbarasi et al., 2005; Sumathy et al., 2002) . Recently, some natural and synthetic triterpenoid saponins such as celastrol, ginsenoside Rg1, and ginsenoside Rb1 from Chinese medicinal plants and 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid methyl ester (CDDO-Me) have also displayed neuroprotection in mice and different in vitro models of PD (Cleren et al., 2005; Gao et al., 2009; Hwang and Jeong, 2010; Yang et al., 2009) . Similarly, one of the most important neuroprotective mechanisms of celastrol and CDDO is their ability to decrease ROS formation through activation of Nrf2-dependent ARE genes (Dinkova-Kostova et al., 2005; Trott et al., 2008; Yang et al., 2009) .
There is a growing interest in identifying new pharmacologic targets that could endorse a neuroprotective therapy together with dopamine replacement for PD. Identification of such targets is therefore a growing priority. There is strong evidence implicating mitochondrial dysfunction, ROS production and oxidative stress, and dysregulation of Nrf2 and Akt pathways in PD. Therefore, therapeutic agents having the ability to target mitochondria and reduce mitochondrial dysfunction hold great promise for therapeutic interventions. The data presented here indicate that BM extract could target these divergent mechanisms. Our investigation is the first comprehensive study aimed at the scientific validation of the traditional use of BM to restore age-related decline of redox homeostasis. We provide novel and important insights into the neuroprotective mechanisms of BM in the hope that this will open up new avenues for its research, application, and therapeutic uses in various age-related neurodegenerative diseases such as PD.
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